Medtronic plc.

Open: 82.37 Close: 82.31 Change: -0.06

The best way to get information about Medtronic plc. Company Inc Stock: Use an AI.

The game is changing. There is a new strategy to evaluate Medtronic plc. fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, stock, device, MDT, SCS, analyst, PLC, …

Concept Map

Semantic Network

Stock Summary

Medtronic plc develops, manufactures, and sells device-based medical therapies. Cardiovascular, medical, surgical, and Neuroscience Portfolio segments offer products for spinal surgeons, neurosurgeons, neurologists, neurologist, pain management.

Today's Summary

Medtronic PLC trades at $81.42 per share, with a market cap of $108.40 billion. Raymond James analysts said in a note late Wednesday that they still believe Medtronics will ultimately get FDA approval. The consensus analyst rating on MDT is a Buy.

Today's News

Medtronic PLC stock rises wed Wednesday, still underperforms market - marketwatch.com. Medtronic PLC ( NYSE:MDT) trades at $81.42 per share, with a market cap of $108.40 billion. The GF Value is a proprietary measure that represents the intrinsic value of a stock. According to GuruFocus Value calculation, the stock of Med Medtronic PLC share price is 82.08 USD today. Will MDT stock go up or go down based on technical indicators? According to simple moving average, exponential moving average and oscillators, the company is overvalued. Real Capital Solutions acquires two-building, 404,159 sf.f. Medtronic Lafayette Campus near Boulder, Colorado. RCS is focused on high-credit, single-tenant net lease. Medtronic recently received CE Mark approval for its Inceptiv closed-loop rechargeable spinal cord stimulator (SCS) The Inceptive SCS system wont be sold or distributed in the United States but will be commercially available in Europe in the upcoming months. Raymond James analysts said in a note late Wednesday that they still believe Medtronics will ultimately get FDA approval. Patient Monitoring Solutions Market Booming at a CAGR of 9% by 2030. Medtronic plc, Koninklijke Philips N.V., Abbott Laboratories. patient monitoring solutions market booming at a cagr of 9%. Medtronic units insulin device device exposes user data, suit says - law360.com. Medical device maker hit the medical device maker with a privacy class action in California federal court Wednesday alleging its smart insulin pen exposed. Medtronic wins ce mark for closed-loop spinal cord stimulator. Dublin-based medtronic plans to launch Inceptiv in Europe in the coming months. Medtronic received CE mark approval for its Inceptiv spinal cord stimulator (SCS) The device is the only SCS system in Europe offering both full-body MRI access. Wall Street analysts consensus recommendation is to buy Medtronic stock. The consensus analyst rating on MDT is a Buy. WallStreetZen was designed to help average investors perform more in-depth fundamental analysis. Wall Street analysts forecast MDT stock price to rise over the next 12 months. The next Medtronic (MDT ) dividend date is projected to be Thursday, September 21, 2023. There is no upcoming split.

Stock Profile

"Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland."

Keywords

This document will help you to evaluate Medtronic plc. without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, stock, device, MDT, SCS, analyst, PLC, and the most common words in the summary are: medtronic, stock, plc, mdt, best, year, market, . One of the sentences in the summary was: Raymond James analysts said in a note late Wednesday that they still believe Medtronics will ultimately get FDA approval. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #medtronic #stock #plc #mdt #best #year #market.